Compassion-Focused Therapy for Prolonged Grief Symptoms
The Aarhus Bereavement Study (TABs): A Randomized Controlled Trial of the Efficacy of Compassion-Focused Therapy for Prolonged Grief Symptoms in Bereaved Adults
1 other identifier
interventional
82
1 country
1
Brief Summary
Prolonged grief disorder (PGD) is a novel diagnostic entity proposed to describe a psychiatric disorder that occurs after the loss of a loved one. The disorder is to be implemented in The International Classification of Diseases 11th Revision (ICD-11), scheduled for release in 2018. Failure to recognize and treat PGD may have negative effects on health, functional capacity and quality of life. However, very little is known about the characteristics and treatment of PGD in adult Danish populations although such knowledge is much needed before introducing the disorder in Danish health services. The present study aims to develop, test and disseminate a group-based treatment manual for PGD in bereaved partners and their adult children. People with high levels of symptoms will be recruited from a large-scale survey study examining frequency, predictors and prognosis of PGD symptoms (NCT03049007). Participants will be randomized to group-based compassion-focused therapy (CFT) for grief or a waitlist control group. Treatment effects will be estimated with prolonged grief symptoms as the primary outcome. Secondary outcomes include depressive symptoms, posttraumatic stress symptoms, symptoms of anxiety, and quality-of-life. The investigators expect that CFT will yield statistically significant effects on prolonged grief symptom compared with the waitlist control group. If CFT is shown to be efficacious in reducing prolonged grief symptoms, the investigators will conduct moderation and mediation analyses with the aim of identifying what works, for whom. Finally, the investigators will perform cost-effectiveness analyses by linking the data with healthcare utilization data from the Danish National registries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2017
CompletedFirst Posted
Study publicly available on registry
December 27, 2017
CompletedStudy Start
First participant enrolled
January 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedNovember 5, 2020
July 1, 2019
2 years
December 14, 2017
November 4, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Prolonged grief symptoms
Prolonged grief (PG-13; Prigerson et al., 2009)
From baseline (T1) to immediately after the intervention (8 weeks) (T2)
Prolonged grief symptoms
Prolonged grief (PG-13; Prigerson et al., 2009)
From baseline (T1) to 6 months after the intervention (T4)
Secondary Outcomes (6)
Prolonged Grief Disorder (PGD) (diagnostic criteria)
From baseline (T1) to 6 months after the intervention (T4)
Anxiety symptoms
From baseline (T1) to 6 months after the intervention (T4)
Depression symptoms
From baseline (T1) to 6 months after the intervention (T4)
Posttraumatic stress symptoms
From baseline (T1) to 6 months after the intervention (T4)
Utility measure
From baseline (T1) to 6 months after the intervention (T4)
- +1 more secondary outcomes
Other Outcomes (11)
Mediator: Self-criticism
Baseline (T1), session-by-session measures (SES1-8), to immediately after the intervention (8 weeks) (T2)
Mediator: Fear of compassion
Baseline (T1), session-by-session measures (SES1-8), to immediately after the intervention (8 weeks) (T2)
Mediator: Experiential avoidance
Baseline (T1), session-by-session measures (SES1-8), to immediately after the intervention (8 weeks) (T2)
- +8 more other outcomes
Study Arms (2)
Compassion-focused therapy
EXPERIMENTALWaitlist control group
NO INTERVENTIONInterventions
CFT for PGD symptoms in the present project is inspired by two well-established CFT treatment manuals. The first is used for treatment of PTSD (Lee \& James, 2011) and the other for treatment of anger (Kolt, 2011). The manual for CFT for PGD adopts both structure and techniques from these into an 8-week, group-based program with weekly 2 1/4-hour sessions. Each session contains elements of psychoeducation on uncomplicated and prolonged grief reactions, identifying unhelpful strategies for self-protection and facilitating use of more helpful strategies, and training an open and compassionate management of grief-related distress through CFT exercises. Between the sessions the participant will train the exercises introduced at the previous session.
Eligibility Criteria
You may qualify if:
- Residence in the Central Region of Denmark
- Status of partner or child to the deceased
- A min. score of 25 on the PG-13 at 11 months after the loss
You may not qualify if:
- Insufficient ability to understand Danish
- Serious psychiatric disease, e.g., schizophrenia, bipolar disease
- Acute suicidal ideation
- Serious cognitive impairment, e.g., Alzheimer's disease
- Active treatment for serious disease, e.g., chemotherapy for cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Utrecht Universitycollaborator
- Columbia Universitycollaborator
- University of Southern Denmarkcollaborator
Study Sites (1)
Unit for Bereavement Research, Dept. of Psychology, Aarhus University
Aarhus C, 8000, Denmark
Related Links
Study Officials
- STUDY DIRECTOR
Maja O'Connor, MSc., PhD
University of Aarhus
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2017
First Posted
December 27, 2017
Study Start
January 3, 2018
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
November 5, 2020
Record last verified: 2019-07